ofloxacin has been researched along with Diabetes Mellitus, Type 1 in 6 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 72-year-old female dialysis patient with insulin-dependent diabetes mellitus who was under long-term medication with oral prednisolone due to chronic obstructive pulmonary disease was given levofloxacin for one week to treat an acute bronchitis (one 500 mg dose on the first day, 125 mg/day orally from second day onwards)." | 3.74 | [Fluoroquinolone-induced Achilles tendon rupture]. ( Maurin, N, 2008) |
| "Cellulitis is usually caused by organisms such as beta-hemolytic streptococci and Staphylococcus aureus." | 1.32 | Sepsis in a renal transplant recipient due to Citrobacter braakii. ( Agraharkar, ML; Gupta, R; Rauf, SJ; Singh, S; Smith, J, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, R | 1 |
| Rauf, SJ | 1 |
| Singh, S | 1 |
| Smith, J | 1 |
| Agraharkar, ML | 1 |
| Benbrika, S | 1 |
| Boukari, L | 1 |
| Stirnemann, J | 1 |
| Letellier, E | 1 |
| Fain, O | 1 |
| Thomas, M | 1 |
| Kettaneh, A | 1 |
| Carranza González, R | 1 |
| Tena Gómez, D | 1 |
| Prieto Gómez, E | 1 |
| Barberá Farré, JR | 1 |
| Fernández Cenjor, J | 1 |
| Maurin, N | 1 |
| Brattström, C | 2 |
| Malmborg, AS | 1 |
| Tydén, G | 2 |
| Malborg, AS | 1 |
6 other studies available for ofloxacin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Sepsis in a renal transplant recipient due to Citrobacter braakii.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Bacteremia; Cellulitis; Citrobacter freundi | 2003 |
[A case of yersiniasis with multiple liver abscesses].
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hemochromatosis; Hepatitis; Humans; Imipenem; | 2005 |
[Pneumonia by Corynebacterium pseudodiphteriticum: an infection to consider].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftriaxone; Corynebacte | 2006 |
[Fluoroquinolone-induced Achilles tendon rupture].
Topics: Achilles Tendon; Aged; Anti-Bacterial Agents; Bronchitis; Diabetes Mellitus, Type 1; Female; Humans; | 2008 |
Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice.
Topics: Adult; Ciprofloxacin; Diabetes Mellitus, Type 1; Half-Life; Humans; Middle Aged; Ofloxacin; Pancreas | 1988 |
Penetration of ciprofloxacin and ofloxacin into pancreatic juice.
Topics: Administration, Oral; Ciprofloxacin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Kidn | 1987 |